insulin resistance may contribute to postprandial hyperglycemia since plasma immunoreactive insulin (IRI) and C peptide immunoreactivity (CPR) levels are increased in patients with LC (3) . Irrespective of etiology, insulin resistance is observed in the patients with LC even before occurring glucose intolerance (4) . Furthermore, diabetes (5, 6) or obesity (5, 7) characterized by insulin resistance increases cancer risk in cirrhosis.
It has been reported that hepatic glucose production in the patients with LC is normal and decreased (8) , however, insulin-induced glucose uptake in the peripheral tissue is markedly decreased (9) . In contrast, hepatic insulin resistance is seen in cirrhotic patients with DM but not in patients with LC alone (9) (10) (11) . Thus, the role of insulin resistance on hepatic glucose uptake in the patients with LC has remained unclear.
There was no clear evidence that etiology, duration and degree in the patients with LC would be related to glucose intolerance (12) . Furthermore, disorder in glucose metabolism is not always seen in a comparative number of cirrhotic patients and the patients with advanced LC is not always developed IGT and DM (12) .
In this study, the relation between glucose uptake of peripheral and liver tissue evaluated by the hyperinsulinemic euglycemic clamp combined with 0.2 g/kg oral glucose load (HECGL), and the biochemical and metabolic parameters of liver function was examined in the patients with LC divided into groups by World Health Organization criteria in 75 g oral glucose tolerance test (OGTT) (13) . HECGL (14) (15) (16) which enabled us to measure the peripheral and hepatic glucose uptake simultaneously and precisely was conducted in 61 patients with LC.
SUBJECTS AND METHODS

Subjects
Sixty-one patients with LC (16 hepatitis B virus (HBV)-infected LC, 35 hepatitis C virus (HCV)-infected LC, 3 HBV-and HCV-infected LC, 2 alcoholic LC and 5 LC with unknown etiology) and 34 age matched control without liver disease (Control) were enrolled for this study. None of the patients received any medication affecting glucose tolerance, including oral hypoglycemic agents or insulin injections. All patients with LC were diagnosed by liver biopsy, laboratory tests and ultrasound sonography ; alcoholic liver disease was diagnosed in habitual drinkers who consumed more than 30 g of ethanol daily. None of the patients had ascites, jaundice or hepatic encephalopathy. 48 and 13 patients in 61 LC patients were classified as Child-Pugh A and B, respectively. The clinical and laboratory data are summarized in Table 1 . The levels of white blood cell, platelet, albumin, cholinesterase, total cholesterol and triglyceride in the patients with LC were significantly lower than those in Control ; body mass index and the levels of serum aspartate aminotransferase, 
Oral glucose tolerance test
After overnight fasting for 12 h, the patients ingested 75 g of dextrose (Torelan G 75, Shimizu Co., Japan) within 5 min. Venous blood was drawn for measuring plasma glucose (PG), IRI and CPR levels before, and at 15, 30, 60 and 120 min after the oral glucose load (OGL). The definition of DM, impaired fasting glucose (IFG), IGT and NGT were based on World Health Organization criteria (13 
Hyperinsulinemic euglycemic clamp combined with oral glucose load
Subjects were admitted to the laboratory at 8 : 00AM after an overnight fast. They voided, were weighed, and then remained supine for the duration of the procedure. The details of HECGL have been described previously (14) (15) (16) . In short, a polyethylene catheter was inserted into an antecubital vein in a retrograde manner to administer glucose (20% of glucose) and insulin infusion. A second catheter was inserted into a dorsal hand vein on the contralateral arm in the retrograde fashion and kept in a warming device to arterialize the venous blood. Blood samples were drawn at baseline to determine Fasting PG levels, serum IRI levels and CPR levels. Insulin-mediated whole body glucose uptake was measured using an artificial pancreas (Model STG-22 Nikkiso, Tokyo, Japan), according to DeFronzo's method (17) . An infusion of 20% of glucose solution was started at baseline, and the rate was adjusted to clamp the glucose level at 100 mg/dl during the clamp study. PG levels were checked at 30-second intervals throughout the investigation. Data on total body glucose uptake represented the mean values for the glucose infusion rate (GIR) during the final 30 minutes of infusion. After determining the baseline GIR during the hyperinsulinemic euglycemic clamp described above, glucose was orally administered at a dose of 0.2 g/kg body weight. Thereafter, the hyperinsulinemic euglycemic clamp was continued and the extent of decrease in GIR was monitored for 90 min in order to evaluate hepatic glucose uptake (HGU), which was used as a parameter of insulin sensitivity in the liver.
Calculation of hepatic glucose uptake
After an OGL during hyperinsulin emiceuglycemic clamp, the glucose appearance rate (Ra(t)) is calculated by the formula,
Ra(t)=[OGL(t)-HGU(t)]+GIR(t)
[1] where OGL(t), the rate of absorption of OGL by the intestine at time t ; HGU(t), the rate of HGU of OGL at time t ; and GIR(t), GIR at time t. Glucose disappearance rate from the systemic circulation (RdT(t)) is calculated by the formula, RdT(t)=RdP(t)+RdS(t)
[2] where RdP(t) and RdS(t) are extra-splanchnic and splanchnic glucose disappearance rates from systemic circulation at time t, respectively. Under hyperinsulinemic euglycemic clamp conditions, Ra(t) is equal to RdT(t), therefore
RdP(t)+RdS(t)=[OGL(t)-HGU(t)]+GIR(t)
[3] HGU can be calculated from the difference between the amount of ingested glucose and the summation of GIR decrements after glucose ingestion.
Σ(HGU(t)+RdS(t))=ΣOGL(t)-Σ(RdP(t)-GIR(t))
[4] Total hepatic glucose uptake was expressed as a percentage of OGL.
Assessment of energy metabolism
To maintain the resting energy expenditure (REE) and substrate oxidation, in preprandial and postprandial thermogenesis after an overnight fast, the patients and Control were asked to maintain a supine position throughout the study period, and to avoid activity during the indirect calorimetry (Chest MI, Tokyo, Japan). The measurements of O2 consumption and CO2 production were computed and printouts obtained at 1 min intervals ; the measurements were continued until steady-state equilibrium was achieved. The average O2 consumption and CO2 production were used in calculating the energy expenditure ; the mean values during the last 10 min of the measurement interval were used for calculation. The machine was calibrated before each study and at intervals throughout the experiment. The basal energy expenditure was estimated according to the equation reported by Harris and Benedict (18) , and the ratio of REE to basal energy expenditure is expressed as the %REE. The %REE was used as the actual index of energy expenditure to compare the values of energy expenditure among different individuals. The non-protein respiratory quotient (npRQ) was calculated from measurements of daily urinary nitrogen excretion. Measurements were taken at 8 : 30AM, 11 : 30AM and 2 : 30PM. The patients were asked to stay in bed for at least 30 minutes before each measurement, but some mobility was allowed between each set of measurements. Breakfast and lunch were given at 9 : 00AM and 12 : 00 noon, respectively, and consumed within 30 min. Patients received standard hospital food, and their dietary intake was recorded and the amounts of energy, protein, fat, and carbohydrate were calculated using Japanese standard tables of food composition (19) . The energy and nutritional intake was not significantly different among the groups. Blood samples were taken to determine the PG and non-esterified fatty acids (NEFA) just before the indirect calorimetry measurements.
Measurement and statistical analysis
Glucose was measured by the glucose oxidase method (Hitachi 736 Auto Analyser, Hitachi Co., Tokyo, Japan). IRI and CPR were analyzed by radioimmunoassay (Eiken, Tokyo, Japan). Serum NEFA concentrations were assayed using an acyl-CoA oxidase-based colorimetric kit (Wako NEFA-C, Wako Chemicals, Osaka, Japan). All data were presented as mean !SE, unless otherwise specified. Statistical comparisons were assessed, where appropriate, using one-way ANOVA and unpaired t-test analysis. P values !0.05 were considered statistically significant.
RESULTS
1) Classification of the patients with LC by 75 g OGTT
By 75 g OGTT, the 61 patients with LC were divided into 21 (34.4%) in LC-NGT, 12 (19.7%) in LC-IGT, 28 (45.9%) in LC-DM, but there were no patients in LC-IFG (Figure 1 ). FPG level was normal in 50 (82.0%) patients with LC. PG in LC-total patients was higher than that in Control at 15, 30, 60 and 120 min. There was not significant difference between Control and LC-DM patients, but PG in LC-DM patients was higher than that in LC-NGT patients and LC-IGT patients at fasting state. Postprandial PG in LC-DM patients was higher than that in LC-NGT patients at 30, 60, 120 min and that in LC-IGT patients at 120 min, respectively. IRI in LCtotal patients was higher than that in Control at 60 and 120 min. There was not significant difference between Control and LC-total patients at fasting state. The Insulin level at fasting state tended to be higher with insulin resistance, but it was not significant. IRI in LC-DM patients was lower than that in LC-NGT patients at 30 min. Similarly, CPR in LC-DM patients was lower than that in LC-NGT patients at 30 min. CPR in LC-total patients was higher than that in Control at 0 and 120 min. The values of area under the curve (AUC) of PG, IRI and CPR levels in LC-total patients were significantly higher than those in Control. The AUC of PG in LC-DM patients higher than that in Control, LC-NGT patients and LC-IGT patients. That in LC-IGT patients higher than that in Control and LC-NGT patients.
The AUC of CPR in LC-IGT patients higher than that in Control (Figure 2) .
The ratios of AUC of IRI to AUC of CPR (AUC IRI/AUC CPR), a rough measurement for porto-systemic shunting of insulin, in LC-total patients, LC-NGT patients, LC-IGT patients and LC-DM patients tended to be higher than those in Control, but not significant.
2) Evaluation of insulin sensitivity
Comparable and stable PG levels, clamped at 1.00 g/L, were achieved over the last 30 min in patients with LC and Control with HECGL. Both GIR and HGU in LC-total patients were significantly lower than those in Control (Figure 3) . GIR in LC-NGT, LC-IGT and LC-DM patients showed significantly lower than that in Control. Furthermore, GIR in LC-DM patients showed significantly lower than that in LC-NGT patients. Thus, GIR levels proportionally became lower with the severity of glucose intolerance. HGU in LC-DM patients showed significantly lower than that in Control.
3) Comparison of biochemical and metabolic features in LC patients
Age was not significant differences among each group. Blood chemistry data exhibited significant differences between Control and LC patients ( Table  1 ). In energy metabolism, the %REE values in the patients with LC and those groups were similar to those of Control under fasting and postprandial conditions (Table 2 ). Fasting npRQ in LC-total patients was significantly lower than that in Control, and the value tended to decrease according to the severity of glucose intolerance in the patients with LC. Furthermore, Fasting npRQ in LC-DM patients showed significantly lower than that in Control. Such findings were not observed after food ingestion. Therefore, the increased npRQ levels after meal, designated as npRQ, in the patients with LC were higher than those in Control, and the value tended to increase according to the severity of glucose intolerance in the patients with LC. Furthermore, "npRQ in LC-DM patients showed significantly higher than that in Control. Fasting and postprandial glucose concentrations in LC-total patients were significantly higher than those in Control. PG in LC patients, at 11 : 30AM and 2 : 30PM, were elevated with the severity of glucose intolerance, which was similar to those of 75 g OGTT. The serum fasting NEFA concentrations in LC-total patients were significantly higher than those in Control and tended to increase with the severity of impaired glucose metabolism in patients with LC. Furthermore, fasting NEFA in LC-DM patients showed significantly higher than that in Control.
DISCUSSION
In this study, we did not find that there were certainly correlation between degree of glucose intolerance and severity of liver dysfunction in the patients with LC. It has been reported that incidence of glucose intolerance in the patients with LC was 60-80% and defined DM was 10-60% (1, 2, 20) .
To verify how many prevalence of glucose intolerance was observed in the patients with LC, 75 g OGTT was firstly conducted in this study. The data in OGTT were compared with those in Control. In this study, the prevalence of NGT, IGT and DM was 34%, 20% and 46%, respectively. Hepatic glucose uptake and peripheral glucose uptake were measured simultaneously using HECGL. The validity of this method for evaluating HGU had been ascertained by the hepatic vein catheterization procedure in humans (15) and in dogs (21) . In the present study, GIR in the patients with LC was significantly lower than that in normal subjects. Furthermore, HGU in them was about 70% of that in Control. GIR decreased depend on severity of glucose intolerance. But HGU did not show significant differences among LC groups. i.e., severity of glucose intolerance was seen to correlate with GIR but not HGU. Recent studies using the hyperinsulinemic euglycemic glucose clamp technique have reported that peripheral insulin sensitivity in the patients with LC was about 30-60% of that in healthy volunteers (9, 10) . The study using a positron-emission tomography study has clarified that in the patients with LC impaired insulin action in the peripheral tissues is characterized by both marked decrease in glucose transport and nonoxidative glucose metabolism under euglycemic state, however, glucose phosphorylation and glucose oxidation have been kept to be intact (22) . In addition, decreased insulin-induced glycogen synthase activity was demonstrated in isolated muscle samples from the patients with LC (23) .
More than 65% of the patients with LC show protein-energy malnutrition because of their increased fat oxidation and decreased glucose oxidation (24) . It was reported that fat oxidation rate measured in starved state after an overnight fast was increased because glycogen stores in the patients with LC was depleted in this condition (24) . The nutritional condition is frequently reduced and about 70% of the patients with LC show some signs of malnutrition (25) . It is well recognized that malnutrition contributes to insulin resistance in the patients with LC (4, 26) . Furthermore, lipotoxicity by NEFA cause insulin resistance (27, 28) . With respect to REE, there was no significant difference in REE between Control and LC patients. As patients with LC have been reported to have either increased (29) , normal (30, 31) , or decreased (32) resting metabolic rates, this issue remains controversial. The variability observed in the patients with LC, although there was no significant difference in REE between Control and the patients with LC. Whenever available, indirect calorimetry should be used to measure REE in the patients with LC.
The mass and function of hepatocytes is reduced in the cirrhotic liver. Collagen accumulation in the Disse's space may disturb glucose permission from endothelial cell of portal vein to hepatocytes (33, 34) . It also reported that insulin resistance is associated with more rapid fibrosis progression in chronic HCV infection (35, 36) . Therefore, it is supposed that complication with DM indicates the advance in liver damage. The relation between glucose intolerance and the biochemical parameters in liver dysfunction, degree of cirrhosis and energy metabolism in the patients with LC was not observed. The average of estimated HGU in the patients with LC and normal subjects were 41.4% and 58.3% in HECGL study, respectively. Previous paper showed HGU was lower in LC patients than in chronic active hepatitis patients and healthy volunteers (37). HGU did not decrease depend on severity of glucose intolerance among LC groups. Thinking about severity of glucose tolerance in LC, but HGU showed significantly lower in LC patients than that in Control. Therefore, our data indicated that postprandial glucose uptake of the liver has already decreased in the patients with LC.
The characteristics of glucose intolerance in the patients with LC are unusual. Although some LC patients exhibit fasting hypoglycemia, they also have postprandial hyperglycemia and continuous hyperinsulinemia (37). Our results also showed that postprandial hyperglycemia was observed in the patients with LC despite fasting glucose levels were normal. In general, insulin resistance is considered to be composed of the following three metabolic defects : 1) reduced glucose uptake by the peripheral tissues ; 2) decreased splanchnic glucose uptake ; 3) overproduction of glucose by the liver. Several studies showed that peripheral and splanchnic glucose utilization is known to be impaired as a result of reduced nonoxidative glucose metabolism in the patients with LC (i.e., glycogen synthesis) (22, 37) . Therefore, the main factor that contributes to postprandial hyperglycemia may be associated with insulin resistance.
It seemed that postprandial hyperinsulinemia may overcome peripheral insulin resistance in the patients with LC (38) so that NGT in OGTT was observed in 30% of patients with LC. Therefore, postprandial hyperglycemia might be one of other compensatory mechanism to disorders in glucose metabolism in the patients with LC, so that the overall glucose disposal is normal in some patients with LC. These findings suggest that glucose intolerance may be initiating event for indicating liver dysfunction and/or altered hepatic circulation in the patients with LC at early stage.
Peripheral insulin resistance characterized by decreased glucose transport and reduced glycogen synthesis in skeletal muscle, whereas the insulininduced increases in glucose phosphorylation, glycolysis and glucose oxidation the patients with LC were reported (4, 22, 23, 39 ). Though, increased insulin level cannot ameliorate disturbed glycogen synthesis and disproportional increase in lactate production in the patients with LC (39). However, glucose transport, glucose phosphorylation, glycolysis, glucose oxidation and glycogen synthesis are all impaired in the patients with type 2 DM (40). Furthermore, it has been reported that further elevation of insulin level can normalize glycogen synthesis and glycolysis but not glucose oxidation and anaerobic glycolysis in the patients with DM (40) . Thus, changes in metabolic characteristics in the cirrhotic patients complicated with DM were obvious. In contrast, impaired insulin extraction and impaired counter regulation based on reduced glycogen store in liver tissue and abnormal glucagon secretion (41) . These facts suggest that the cirrhotic patients complicated with DM will be fallen into hypoglycemia.
We concluded from the present study that insulin resistance in both liver and peripheral tissues is the early etiology of metabolic abnormality in the patients with LC and precious nutritional care will be needed at early stage of LC.
